Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
about
Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.TLR Agonists as Adjuvants for Cancer Vaccines.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer.Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.The revival of CpG oligonucleotide-based cancer immunotherapies.Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors.Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies
P2860
Q33710042-79C792C4-5043-42C2-8129-BE2E9F5C6401Q37685388-8E7362FB-6032-49AC-98BB-19096033E83AQ41886564-2769A457-54A9-43E8-A491-100EA895E6F7Q41997055-85B4FA66-8C3A-446C-B57F-C6E88D6D2EF3Q47120629-47333367-B60F-4121-8ABE-4D71F9927CD7Q47224779-1512F8DE-BDE0-41E9-9521-12893ABBB862Q52647698-9DF0F5B3-034B-40A4-B83E-2B64E304AF92Q52647752-E3A1E16A-0F89-41F0-A07B-30773C0EF5BDQ55034836-E41B20C5-6ACD-4764-BF31-933E902C9DFDQ55352057-004DAF53-BA17-40BB-BB5E-16223A585266Q55401761-3A5A03A7-28A8-46C9-BBFE-8A414A720F67Q55414494-A83B9381-6B69-4557-A818-405BD4C8FC70Q58803983-0FBF72A2-51DE-4913-9F54-0C843C61C4A1
P2860
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@en
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@nl
type
label
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@en
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@nl
prefLabel
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@en
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@nl
P2093
P2860
P356
P1476
Intratumoral injection of a Cp ...... multifunctional CD8+ T cells.
@en
P2093
Chad Crain
Cristiana Guiducci
Edwina Naik
Jose Campos
Marilena Gallotta
Robert L Coffman
P2860
P304
E7240-E7249
P356
10.1073/PNAS.1608555113
P407
P577
2016-10-31T00:00:00Z